Masaaki Odomi
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 5
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 14
- Antibiotics Pharmacokinetics and Efficacy 9
- Drug-Induced Hepatotoxicity and Protection 6
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals 5
- Spectroscopy top 10%
- Analytical Chemistry and Chromatography 5
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 14
- Antibiotics Pharmacokinetics and Efficacy 9
- Drug-Induced Hepatotoxicity and Protection 6
-
- Drug Transport and Resistance Mechanisms 17
-
- Gastroesophageal reflux and treatments 3
Masaaki Odomi
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 121
- Pharmaceutical Science 505
- Pharmacology 170
- Analytical Chemistry 105
- Spectroscopy 108
- Pharmacology 104
Countries citing papers authored by Masaaki Odomi
This map shows the geographic impact of Masaaki Odomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Odomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Odomi more than expected).
Fields of papers citing papers by Masaaki Odomi
This network shows the impact of papers produced by Masaaki Odomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Odomi. The network helps show where Masaaki Odomi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaaki Odomi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 13 | |
| 2 | 2009 | 1 | |
| 3 | 2008 | 58 | |
| 4 | 2006 | 20 | |
| 5 | 2005 | 40 | |
| 6 | 2004 | 21 | |
| 7 | 2004 | 30 | |
| 8 | 2000 | 9 | |
| 9 | 1999 | 3 | |
| 10 | 1998 | 10 | |
| 11 | 1997 | 0 | |
| 12 | 1997 | 9 | |
| 13 | 1996 | 1 | |
| 14 | 1996 | 5 | |
| 15 | Pharmacokinetics of grepafloxacin (IV):Metabolism after oral administration of grepafloxacin in rats, monkeys and humans | 1995 | 8 |
| 16 | 1994 | 6 | |
| 17 | 1994 | 20 | |
| 18 | 1991 | 3 | |
| 19 | 1989 | 1 | |
| 20 | 1989 | 1 |
About Masaaki Odomi
Masaaki Odomi is a scholar working on Pharmacology, Pharmaceutical Science and Pharmacology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Analytical Chemistry and Chromatography (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Advanced Drug Delivery Systems (5 papers) and Gastroesophageal reflux and treatments (3 papers). The work is most often cited by research in Pharmaceutical Science (505 citations), Pharmacology (170 citations) and Analytical Chemistry (105 citations). Masaaki Odomi has collaborated with scholars based in Japan, Spain and United States. Frequent co-authors include Kazutaka Higaki, Toshikiro Kimura, Masateru Miyake, Hajime Toguchi, T. Mukai, Keigo Yamada, Naoki Kamada, Gary G. Liversidge, Ken‐ichi Ogawara and Toshio Matsumoto. Their work appears in journals such as Cancer, Journal of Controlled Release and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.